(Q37773790)

22 August 2017

1 reference

title

AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance (English)

1 reference

22 August 2017

0 references

0 references

1 reference

1 reference

1

Sven Jarius

1 reference

22 August 2017

2

Brigitte Wildemann

1 reference

PubMed ID

20639914

22 August 2017

language of work or name

English

0 references

publication date

1 July 2010

1 reference

22 August 2017

Nature Reviews Neurology

1 reference

22 August 2017

6

1 reference

22 August 2017

7

1 reference

22 August 2017

383-392

1 reference

https://scigraph.springernature.com/pub.10.1038/nrneurol.2010.72

22 August 2017

0 references

cites work

The clinical course of neuromyelitis optica (Devic's syndrome).

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Devic's neuromyelitis optica: clinical, laboratory, MRI and outcome profile.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Plasma exchange for severe attacks of CNS demyelination: predictors of response

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

NMO-IgG predicts the outcome of recurrent optic neuritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Antibody to aquaporin-4 in the long-term course of neuromyelitis optica

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Plasma exchange in severe spinal attacks associated with neuromyelitis optica spectrum disorder

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

An open label study of the effects of rituximab in neuromyelitis optica

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Aquaporin-4 antibody positive longitudinally extensive transverse myelitis following varicella zoster infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

B lineage cells in the inflammatory central nervous system environment: migration, maintenance, local antibody production, and therapeutic modulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Absence of aquaporin-4 expression in lesions of neuromyelitis optica but increased expression in multiple sclerosis lesions and normal-appearing white matter

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Loss of aquaporin-4 in active perivascular lesions in neuromyelitis optica: a case report

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Pathologic and immunologic profiles of a limited form of neuromyelitis optica with myelitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Humoral pattern II multiple sclerosis pathology not associated with neuromyelitis Optica IgG

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Marked increase in cerebrospinal fluid glial fibrillar acidic protein in neuromyelitis optica: an astrocytic damage marker.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

High CSF neurofilament heavy chain levels in neuromyelitis optica

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Markedly increased CSF interleukin-6 levels in neuromyelitis optica, but not in multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

B-cell activating factor of the TNF family is upregulated in neuromyelitis optica

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Enhanced IL-6 production in aquaporin-4 antibody positive neuromyelitis optica patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Immune system markers of neuroinflammation in patients with clinical diagnose of neuromyelitis optica

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Aquaporin-4 autoimmune syndrome and anti-aquaporin-4 antibody-negative opticospinal multiple sclerosis in Japanese

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Activation of humoral immunity and eosinophils in neuromyelitis optica

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Functional consequences of neuromyelitis optica-IgG astrocyte interactions on blood-brain barrier permeability and granulocyte recruitment.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Anti-aquaporin-4 antibody induces astrocytic cytotoxicity in the absence of CNS antigen-specific T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Altered blood-brain barrier integrity in adult aquaporin-4 knockout mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Extensive vasogenic edema of anti-aquaporin-4 antibody-related brain lesions.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Aquaporin-4 deficiency down-regulates glutamate uptake and GLT-1 expression in astrocytes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

The link between excitotoxic oligodendroglial death and demyelinating diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Activation of Kainate Receptors Sensitizes Oligodendrocytes to Complement Attack

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Complement expression on astrocytes and astrocytoma cell lines: failure of complement regulation at the C3 level correlates with very low CD55 expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Astrocytic necrosis is induced by anti-aquaporin-4 antibody-positive serum.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Cytotoxic effect of neuromyelitis optica antibody (NMO-IgG) to astrocytes: an in vitro study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Hypercomplementemia at relapse in patients with anti-aquaporin-4 antibody

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Immunoglobulin M antibodies to aquaporin-4 in neuromyelitis optica and related disorders

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Anti-aquaporin-4 auto-antibodies orchestrate the pathogenesis in neuromyelitis optica

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Identification of binding sites for anti-aquaporin 4 antibodies in patients with neuromyelitis optica

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Aquaporin-4 orthogonal arrays of particles are the target for neuromyelitis optica autoantibodies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Aquaporin-4 square array assembly: opposing actions of M1 and M23 isoforms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Live cell analysis of aquaporin-4 m1/m23 interactions and regulated orthogonal array assembly in glial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Western blot analysis for the detection of serum antibodies recognizing linear Aquaporin-4 epitopes in patients with Neuromyelitis Optica

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Neuromyelitis optica: Passive transfer to rats by human immunoglobulin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

A case of NMO seropositive for aquaporin-4 antibody more than 10 years before onset

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Neuromyelitis optica (Devic's disease) following chicken pox

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Neuromyelitis optica (Devic disease)_following varicella infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Neuromyelitis optica following CMV primo-infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Clinical characteristics, course and prognosis of relapsing Devic's Neuromyelitis Optica.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

NMO-IgG in the diagnosis of neuromyelitis optica.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

OSMS is NMO, but not MS: proven clinically and pathologically

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Establishment of a new sensitive assay for anti-human aquaporin-4 antibody in neuromyelitis optica.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Neuromyelitis optica-IgG (aquaporin-4) autoantibodies in immune mediated optic neuritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Intractable hiccup and nausea in neuromyelitis optica with anti-aquaporin-4 antibody: a herald of acute exacerbations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

CNS aquaporin-4 autoimmunity in children

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Autoantibodies against aquaporin-4 in patients with neuropsychiatric systemic lupus erythematosus and primary Sjögren's syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Paraneoplastic autoimmune optic neuritis with retinitis defined by CRMP-5-IgG.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Devic's syndrome-like phenotype associated with thymoma and anti-CV2/CRMP5 antibodies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

NMO-IgG detected in CSF in seronegative neuromyelitis optica

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Crystal structure of human aquaporin 4 at 1.8 A and its mechanism of conductance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

The Molecular Biology Toolkit (MBT): a modular platform for developing molecular visualization applications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Seroprevalence of NMO-IgG antibody in Brazilian patients with neuromyelitis optica

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

NMO-IgG and Devic's neuromyelitis optica: a French experience.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Revised diagnostic criteria for neuromyelitis optica (NMO). Application in a series of suspected patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Prevalence of neuromyelitis optica spectrum disorder and phenotype distribution

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Revised diagnostic criteria for neuromyelitis optica

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

AQP4-IgG immunoprecipitation assay optimization.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.72

Aquaporin-4 autoantibodies in a paraneoplastic context

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20639914

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Neuromyelitis optica and non organ-specific autoimmunity

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20639914

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRNEUROL.2010.72

1 reference

22 August 2017

1 reference

PubMed ID

20639914